319 related articles for article (PubMed ID: 29594118)
1. The Many Faces of Primary Aldosteronism and Cushing Syndrome: A Reflection of Adrenocortical Tumor Heterogeneity.
Mete O; Duan K
Front Med (Lausanne); 2018; 5():54. PubMed ID: 29594118
[TBL] [Abstract][Full Text] [Related]
2. Molecular Basis of Primary Aldosteronism and Adrenal Cushing Syndrome.
Vaduva P; Bonnet F; Bertherat J
J Endocr Soc; 2020 Sep; 4(9):bvaa075. PubMed ID: 32783015
[TBL] [Abstract][Full Text] [Related]
3. Molecular Genetic and Genomic Alterations in Cushing's Syndrome and Primary Aldosteronism.
Kamilaris CDC; Stratakis CA; Hannah-Shmouni F
Front Endocrinol (Lausanne); 2021; 12():632543. PubMed ID: 33776926
[TBL] [Abstract][Full Text] [Related]
4. Genetic Alterations in Benign Adrenal Tumors.
Pitsava G; Stratakis CA
Biomedicines; 2022 Apr; 10(5):. PubMed ID: 35625779
[TBL] [Abstract][Full Text] [Related]
5. Overview of the 2022 WHO Classification of Adrenal Cortical Tumors.
Mete O; Erickson LA; Juhlin CC; de Krijger RR; Sasano H; Volante M; Papotti MG
Endocr Pathol; 2022 Mar; 33(1):155-196. PubMed ID: 35288842
[TBL] [Abstract][Full Text] [Related]
6. Adrenocortical tumorigenesis: Lessons from genetics.
Kamilaris CDC; Hannah-Shmouni F; Stratakis CA
Best Pract Res Clin Endocrinol Metab; 2020 May; 34(3):101428. PubMed ID: 32507359
[TBL] [Abstract][Full Text] [Related]
7. Update of Genetic and Molecular Causes of Adrenocortical Hyperplasias Causing Cushing Syndrome.
Berthon A; Bertherat J
Horm Metab Res; 2020 Aug; 52(8):598-606. PubMed ID: 32097969
[TBL] [Abstract][Full Text] [Related]
8. How does cAMP/protein kinase A signaling lead to tumors in the adrenal cortex and other tissues?
Almeida MQ; Stratakis CA
Mol Cell Endocrinol; 2011 Apr; 336(1-2):162-8. PubMed ID: 21111774
[TBL] [Abstract][Full Text] [Related]
9. ENDOCRINE TUMOURS: The genomics of adrenocortical tumors.
Faillot S; Assie G
Eur J Endocrinol; 2016 Jun; 174(6):R249-65. PubMed ID: 26739091
[TBL] [Abstract][Full Text] [Related]
10. Novel Insights into the Genetics and Pathophysiology of Adrenocortical Tumors.
Drougat L; Omeiri H; Lefèvre L; Ragazzon B
Front Endocrinol (Lausanne); 2015; 6():96. PubMed ID: 26106367
[TBL] [Abstract][Full Text] [Related]
11. Novel somatic mutations and distinct molecular signature in aldosterone-producing adenomas.
Åkerström T; Willenberg HS; Cupisti K; Ip J; Backman S; Moser A; Maharjan R; Robinson B; Iwen KA; Dralle H; D Volpe C; Bäckdahl M; Botling J; Stålberg P; Westin G; Walz MK; Lehnert H; Sidhu S; Zedenius J; Björklund P; Hellman P
Endocr Relat Cancer; 2015 Oct; 22(5):735-44. PubMed ID: 26285814
[TBL] [Abstract][Full Text] [Related]
12. Genomics of benign adrenocortical tumors.
Jouinot A; Armignacco R; Assié G
J Steroid Biochem Mol Biol; 2019 Oct; 193():105414. PubMed ID: 31207362
[TBL] [Abstract][Full Text] [Related]
13. Primary bilateral macronodular adrenocortical hyperplasia (PBMAH) patient with ARMC5 mutations.
Tang P; Zhang J; Peng S; Yan X; Wang Y; Wang S; Zhang Y; Liu G; Xu J; Huang Y; Zhang D; Liu Q; Jiang J; Lan W
BMC Endocr Disord; 2023 Apr; 23(1):77. PubMed ID: 37029354
[TBL] [Abstract][Full Text] [Related]
14. Genetics of tumors of the adrenal cortex.
Bonnet-Serrano F; Bertherat J
Endocr Relat Cancer; 2018 Mar; 25(3):R131-R152. PubMed ID: 29233839
[TBL] [Abstract][Full Text] [Related]
15. PRKACA mutations in cortisol-producing adenomas and adrenal hyperplasia: a single-center study of 60 cases.
Thiel A; Reis AC; Haase M; Goh G; Schott M; Willenberg HS; Scholl UI
Eur J Endocrinol; 2015 Jun; 172(6):677-85. PubMed ID: 25750087
[TBL] [Abstract][Full Text] [Related]
16. Phosphodiesterase 11A expression in the adrenal cortex, primary pigmented nodular adrenocortical disease, and other corticotropin-independent lesions.
Boikos SA; Horvath A; Heyerdahl S; Stein E; Robinson-White A; Bossis I; Bertherat J; Carney JA; Stratakis CA
Horm Metab Res; 2008 May; 40(5):347-53. PubMed ID: 18491255
[TBL] [Abstract][Full Text] [Related]
17. Molecular mechanisms of
Stratakis CA; Berthon A
Curr Opin Endocr Metab Res; 2019 Oct; 8():104-111. PubMed ID: 32864505
[TBL] [Abstract][Full Text] [Related]
18. Genetics of primary hyperaldosteronism.
Dutta RK; Söderkvist P; Gimm O
Endocr Relat Cancer; 2016 Oct; 23(10):R437-54. PubMed ID: 27485459
[TBL] [Abstract][Full Text] [Related]
19. Alterations of Phosphodiesterases in Adrenocortical Tumors.
Hannah-Shmouni F; Faucz FR; Stratakis CA
Front Endocrinol (Lausanne); 2016; 7():111. PubMed ID: 27625633
[TBL] [Abstract][Full Text] [Related]
20. Adrenal nodularity and somatic mutations in primary aldosteronism: one node is the culprit?
Dekkers T; ter Meer M; Lenders JW; Hermus AR; Schultze Kool L; Langenhuijsen JF; Nishimoto K; Ogishima T; Mukai K; Azizan EA; Tops B; Deinum J; Küsters B
J Clin Endocrinol Metab; 2014 Jul; 99(7):E1341-51. PubMed ID: 24758183
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
